Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Biguanides, and Others), Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), End User (Male, Female), and Region 2024-2032
The global infertility drugs market size reached US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032.
Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.
Infertility Drugs Market Trends:
Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.
Breakup by Drug Class:
Gonadotropin
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Biguanides
Others
Breakup by Route of Administration:
Oral
Intravenous
Subcutaneous
Intramuscular
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
Breakup by End User:
Male
Female
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.
Key Questions Answered in This Report:
How has the global infertility drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global infertility drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global infertility drugs market and who are the key players?
What is the degree of competition in the industry?
Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.
Infertility Drugs Market Trends:
Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.
Breakup by Drug Class:
Gonadotropin
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Biguanides
Others
Breakup by Route of Administration:
Oral
Intravenous
Subcutaneous
Intramuscular
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
Breakup by End User:
Male
Female
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.
Key Questions Answered in This Report:
How has the global infertility drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global infertility drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global infertility drugs market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFERTILITY DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Gonadotropin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aromatase Inhibitors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Selective Estrogen Receptor Modulators (SERMs)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Biguanides
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Subcutaneous
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Intramuscular
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Male
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Female
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Bayer AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Ferring Pharmaceuticals
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Livzon Pharmaceutical Group Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Mankind Pharma
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Merck & Co. Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Theramex
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFERTILITY DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Gonadotropin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aromatase Inhibitors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Selective Estrogen Receptor Modulators (SERMs)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Biguanides
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Subcutaneous
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Intramuscular
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Male
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Female
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Bayer AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Ferring Pharmaceuticals
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Livzon Pharmaceutical Group Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Mankind Pharma
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Merck & Co. Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Theramex
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
LIST OF TABLES
Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Infertility Drugs Market: Competitive Structure
Table 8: Global: Infertility Drugs Market: Key Players
Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Infertility Drugs Market: Competitive Structure
Table 8: Global: Infertility Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2023
Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2023
Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2023
Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2023
Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis
